Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-20
SponsorColumbia University

About this trial

Rapid onset Obesity, Hypoventilation, Hypothalamic dysfunction and Autonomic Dysregulation (ROHHAD) is a syndrome named in 2007. The hallmark of the syndrome is the rapid onset obesity and dysregulation of central ventilation. There is little information about the metabolic changes that lead to the rapid onset obesity in these children. The investigators would like to study the metabolic phenotype of these children to understand the disturbances in energy balance that lead to the rapid onset obesity.

Eligibility criteria

Qualifiers

Children with ROHHAD syndrome

Disqualifiers

Children with known genetic causes of obesity

Trial design

Treatments tested in this trial

  • Transcriptome profiling

Treatment groups

12 Participants
are divided into 2 treatment groups

Locations

2
Boston Children's Hospital02115, BostonNew York, United States
Columbia University Irving Medical Center10032, New YorkNew York, United States

Sponsors and collaborators

Columbia University

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

ROHHAD Association

Collaborator